NEW YORK (GenomeWeb News) – GnuBio today said that it has completed a $10 million Series B round of financing with private investors.

The Cambridge, Mass.-based firm didn't disclose the names of the investors but said that the round included investors from its Series A round. GnuBio completed that $8 million Series A round a year ago, and it also declined to disclose the names of the investors at that time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.